No Impact of Hepatitis C Virus Infection on Mortality Among Drug Users During the First Decade After Seroconversion

cHCV infection does not affect overall mortality in the first decade after seroconversion, compared with individuals who resolve HCV infection; however, during the second decade after infection, individuals with cHCV have an increased risk for all-cause mortality. Mortality from liver-related causes was low but might have been masked by competing mortality.